HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Uterine arteriovenous malformation after gestational trophoblastic disease: a report of two cases.

AbstractBACKGROUND:
Uterine arteriovenous malformation (AVM) is considered a rare condition. Diagnosis is critical because patients are at risk of significant vaginal hemorrhage that has been traditionally managed with surgery.
CASE:
We report 2 cases of uterine AVM after gestational trophoblastic disease in young women who were treated with uterine artery embolization, allowing preservation of reproductive capability.
CONCLUSION:
Embolization addresses both the preservation of future reproductive function and the prevention of major surgery and anesthesia. Success rates have been quoted as > 90% with minimal complications after uterine artery embolization.
AuthorsDaniela Angerame Yela, Juliana Yoneda, Lisa Brasil
JournalThe Journal of reproductive medicine (J Reprod Med) 2014 Jul-Aug Vol. 59 Issue 7-8 Pg. 417-20 ISSN: 0024-7758 [Print] United States
PMID25098034 (Publication Type: Case Reports, Journal Article)
Topics
  • Adolescent
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Arteriovenous Malformations (diagnostic imaging, therapy)
  • Female
  • Humans
  • Hydatidiform Mole (therapy)
  • Pregnancy
  • Radiography
  • Ultrasonography, Doppler
  • Uterine Artery (abnormalities, diagnostic imaging)
  • Uterine Artery Embolization
  • Uterine Neoplasms (therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: